Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROCK-T: Long-Term Intraocular Pressure-Lowering Effects and Adverse Events of Ripasudil in Thai Patients with Glaucoma or Ocular Hypertension
TCTR20260305002Phase 4Not yet recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ripasudil in Glaucoma, ocular hypertension, sponsored by Kowa Company, Ltd.. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
ripasudil
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on TCTR20260305002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260305002.